Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Exact Sciences Corporation - Common Stock
(NQ:
EXAS
)
102.39
+0.04 (+0.04%)
Streaming Delayed Price
Updated: 12:00 PM EST, Jan 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics
↗
November 20, 2025
Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum.
Via
Benzinga
EXAS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Exact Sciences Corporation is Fair to Shareholders
November 20, 2025
From
Halper Sadeh LLC
Via
Business Wire
Abbott To Acquire Exact Sciences For Up To $23B
↗
November 20, 2025
Under the deal, Exact Sciences shareholders will receive $105 per common share in cash.
Via
Stocktwits
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover
↗
November 20, 2025
Via
Stocktwits
Why Exact Sciences Stock Blasted Nearly 24% Higher Today
↗
November 19, 2025
A strategic investor is reportedly in advanced talks to purchase the company.
Via
The Motley Fool
Earnings Scheduled For November 3, 2025
↗
November 03, 2025
Via
Benzinga
Earnings Preview: Exact Sciences
↗
October 31, 2025
Via
Benzinga
2 Surging Stocks with Competitive Advantages and 1 We Question
November 16, 2025
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...
Via
StockStory
Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests
November 10, 2025
From
Exact Sciences Corp.
Via
Business Wire
The 5 Most Interesting Analyst Questions From Exact Sciences’s Q3 Earnings Call
November 10, 2025
Exact Sciences’ third quarter results received a positive response from the market, reflecting strong revenue growth and robust execution in its core screening business. Management attributed the...
Via
StockStory
Topics
Earnings
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
↗
November 08, 2025
These companies are slowly coming into their own.
Via
The Motley Fool
Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test
November 07, 2025
From
Exact Sciences Corp.
Via
Business Wire
Why Exact Sciences Stock Blasted Higher on Tuesday
↗
November 04, 2025
An impressive beat-and-raise third quarter made the company a standout that day.
Via
The Motley Fool
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results
↗
November 04, 2025
Via
Benzinga
Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday?
↗
November 04, 2025
Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date...
Via
Benzinga
Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
November 04, 2025
Via
Benzinga
EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth
November 04, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year...
Via
StockStory
Exact Sciences to Participate in November Investor Conference
November 04, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences (EXAS) Q3 2025 Earnings Transcript
↗
November 03, 2025
Exact Sciences (EXAS) Q3 2025 Earnings Transcript
Via
The Motley Fool
Topics
Earnings
Exact Sciences (NASDAQ:EXAS) Reports Upbeat Q3, Stock Soars
November 03, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year...
Via
StockStory
Exact Sciences Flirts With A Breakout On Guidance Hike, Sales Beat
↗
November 03, 2025
Exact Sciences stock jumped late Monday on strong third-quarter sales, despite continued losses. The company raised its sales guide.
Via
Investor's Business Daily
Topics
Earnings
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 03, 2025
Via
Benzinga
Exact Sciences Announces Third Quarter 2025 Results
November 03, 2025
From
Exact Sciences Corp.
Via
Business Wire
Should You Buy Exact Sciences Stock Before Nov. 3?
↗
November 02, 2025
The company's outlook is improving as its innovative ways continue to pay off.
Via
The Motley Fool
Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?
↗
November 03, 2025
Wall Street opened the week on a mixed note on Monday.
Via
Benzinga
Exact Sciences (EXAS) Reports Q3: Everything You Need To Know Ahead Of Earnings
November 01, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be announcing earnings results this Monday after market hours. Here’s what to expect.
Via
StockStory
3 Unprofitable Stocks with Questionable Fundamentals
October 30, 2025
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Via
StockStory
3 Cash-Producing Stocks We Think Twice About
October 28, 2025
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via
StockStory
Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps
October 27, 2025
From
Exact Sciences Corp.
Via
Business Wire
11 Analysts Have This To Say About Exact Sciences
↗
October 22, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
